Herbal Medicine Composition for Dengue Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for dengue are inadequate in addressing the severe pathophysiologic conditions such as viral multiplication, increased vascular permeability, and reduced platelet count, with no definitive drug treatment available.

Innovation Solution

A herbal medicine composition is developed using dried and finely powdered leaves of Lagerstroemia speciosa, aerial parts of Euphorbia hirta, and rhizome of Zingiber officinale, combined in a fixed-dose formulation to target viral multiplication, vascular permeability, and platelet count.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for dengue, then general symptomatic relief is provided, but severe pathophysiologic conditions (viral multiplication, vascular permeability, platelet count) are not effectively addressed

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidability to address multiple pathophysiologic conditions
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines three distinct herbal extracts (Lagerstroemia speciosa, Euphorbia hirta, and Zingiber officinale) into a single fixed-dose composition, where each component targets a specific pathophysiologic aspect: L. speciosa for viral multiplication, E. hirta for platelet count elevation, and Z. officinale for vascular permeability reduction. This merging of multiple functional components into one formulation resolves the contradiction by providing comprehensive treatment coverage while maintaining a unified product structure.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The herbal composition is designed with multi-functionality to address three critical pathophysiologic conditions simultaneously: antiviral activity against dengue virus, elevation of platelet count in thrombocytopenic patients, and reduction of vascular permeability. This universal approach allows a single treatment to adapt to multiple disease manifestations, resolving the limitation of conventional single-function treatments.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If a fixed-dose combination of multiple herbal extracts is used, then comprehensive treatment coverage is achieved, but formulation complexity increases

Engineering Contradiction:
Improvecomprehensive treatment coverageVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges three separate herbal extracts into a single fixed-dose combination formulation with standardized ratios. This merging approach achieves comprehensive treatment coverage by incorporating multiple active components while simplifying the patient regimen to a single dosage form, thereby resolving the formulation complexity issue through unified product design.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent establishes specific parameter standards for the fixed-dose combination, including defined ratios of herbal extracts, standardized extraction methods, and controlled dosage parameters. By setting precise parameters for composition and preparation, the patent manages formulation complexity through quantifiable standards while maintaining comprehensive treatment coverage.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250170202A1Herbal medicine composition for treatment of dengue and their production
Publication Date: 2025.05.29 PHARMALYTICS CORP
  • US20250170202A1 patent drawing

AI summary

This invention relates to herbal medicine compositions for the treatment of dengue and their production. The herbal medicine compositions consist of dried and finely powdered leaves of Lagerstroemia speciosa; dried and finely powdered aerial parts of Euphorbia hirta; dried and finely powdered rhizome of Zingiber officinale; and a fixed-dose combination of all three. In another version of the formulation, the spray-dried aqueous, ethanolic, methanolic or hydroalcoholic extract of the mentioned plants were used instead.